My ambition is to contribute to reducing information asymmetry on access to care and finding points of convergence between stakeholders. To that end I work on and support projects, which aim at - making existing resources on access to care more visible and accessible; - making patients' voices heard in health care decisions, most notably in access to care; - developing information platforms and service to improve patient journeys. I collaborate with Patvocates on pan-European patient advocacy projects. In that capacity, I supported Myeloma Patient Europe on their access to medicines programme from April 2020 to January 2023.

Led the market access strategy for second-line metastatic colorectal cancer biologic Zaltrap (aflibercept) and provided market access input to preclinical to phase II oncology portfolio in hormone positive and HER2 negative breast cancer, non-squamous non-small cell lung cancer, melanoma, acute myeloid leukemia and bladder cancer.

Contributed to the market strategy and launch of Praluent (alirocumab) in Europe

Developed the Global P&R strategy for alcohol-dependence drug Selincro (nalmefene)

Writing and edition of the 2008, 2009 and 2010 editions of KantarHealth's syndicated report "Oncology Market Europe", which required setting up and managing a network of advisers to payers, health economists and KOLs.

Developed INCa's nutrition and set up its first cancer research grant program. Worked with international institutions, including World Health Organization and the International Agency for Research on Cancer, public health NGOs, key opinion leaders and scientists to issue INCa’s position statements on the link between nutrition, lifestyle and cancerSupported INCa's communication department in their general public awareness initiatives.

Was trained in cancer prevention awareness campaigns, scientific board and research grant management and fundraising campaigning. Managed the French department of the World Cancer Research Fund in the London and DC offices in 2001-2002. Set up the Fonds Mondial de Recherche sur le Cancer, the Paris-based office and launched the charity's first fundraising campaign in 2003-2004Secured partnerships with the Ligue contre le Cancer, the French Ministry of Health and the scientific NACRe network, which led to co-authoring the publication "Alimentation, nutrition et prévention des cancers, une perspective mondiale : application au contexte français".

Conducted desk research and interviews for the book "Hospital in a changing Europe" from Judith Healy and David McKee, with a special focus on Chapter 10 "Improving performance within the hospital". Undertook desk research on comparative proxy demand in outpatient care in France and the UK to support LSE Health and Social Care publications. The European Observatory on Health Systems and Policies supports and promotes evidence-based health policy-making through comprehensive and rigorous analysis of the dynamics of health care systems in Europe. The Observatory is a partnership that includes governments, international organisations including WHO and the London School of Economics (LSE) and the London School of Hygiene & Tropical Medicine (LSHTM).

Monitored EU policy changes and inform DeHavilland syndicated syndicated database.DeHavilland delivers political intelligence to public affairs and communication professionals within businesses, membership organisations, charities and in the public sector.